Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Non-cash Items (2023 - 2025)

Cardiff Oncology (CRDF) has disclosed Non-cash Items for 8 consecutive years, with $9.8 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items fell 16.02% to $9.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.8 million through Dec 2025, down 16.02% year-over-year, with the annual reading at $9.8 million for FY2025, 16.02% down from the prior year.
  • Non-cash Items hit $9.8 million in Q4 2025 for Cardiff Oncology, up from $6.3 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $11.7 million in Q4 2024 to a low of $23926.0 in Q4 2023.
  • Historically, Non-cash Items has averaged $6.1 million across 3 years, with a median of $5.4 million in 2025.
  • Biggest five-year swings in Non-cash Items: surged 48671.17% in 2024 and later fell 16.02% in 2025.
  • Year by year, Non-cash Items stood at $23926.0 in 2023, then soared by 48671.17% to $11.7 million in 2024, then dropped by 16.02% to $9.8 million in 2025.
  • Business Quant data shows Non-cash Items for CRDF at $9.8 million in Q4 2025, $6.3 million in Q3 2025, and $4.8 million in Q2 2025.